The effect of Melissa officinalis on the treatment of children with attention deficit hyperactivity disorder
Phase 3
- Conditions
- Attention deficit hyperactivity disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20190330043139N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Children aged 6-15 years old
Diagnosis of Attention deficit hyperactivity disorder(ADHD) based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition(DSM-V)
Filling the consent form
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients with Attention deficit hyperactivity disorder (ADHD). Timepoint: Before starting the study and at 0, 4, and 8 weeks after starting treatment. Method of measurement: Integrated visual Auditory(IVA)- Conners-Clinical Q- Quantitative Electroencephalography (qEEG) tests.
- Secondary Outcome Measures
Name Time Method